Osteoarthritis, Hip  >>  Palexia RP (tapentadol extended release)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma
NCT00361504: A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain

Completed
3
1123
US, Canada
Oxycodone CR, Tapentadol (CG5503) ER, CG5503
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Grünenthal GmbH
Osteoarthritis, Hip, Osteoarthritis, Knee, Lower Back Pain, Pain
07/08
07/08

Download Options